COMP <GO>
BDX vs MDLN // ENTERPRISE SCALE & MARKET CAP
Becton Dickinson and Company (NYSE) VS. Medline Inc. (NASDAQ) • 15-METRIC TALLY: BDX 5
— MDLN 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BDX
LAST: $197.88 (-0.23%) • MKT CAP: $54.03B
market-cap
$54.03B
LAST: $32.12 (+0.38%) • MKT CAP: $42.07B
market-cap
$42.07B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDX VS. MDLN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDX | MDLN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 8.20% | -3.30 | MDLN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 20.3x | +1.50 | MDLN | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 3.08% | -0.95 | MDLN | /fcf-yield <GO> |
| Operating Margin | 11.80% | 7.80% | +4.00 | BDX | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 68.00% | -60.30 | MDLN | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 11.50% | -3.30 | MDLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.21% | 0.00% | +2.21 | BDX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 2.50 | -0.28 | MDLN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | BDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.6 | 30.9 | +33.70 | BDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.11 | -0.05 | MDLN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $54.03B | $42.07B | $11.95B | BDX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDX REV | MDLN REV | BDX GROSS % | MDLN GROSS % | BDX FCF | MDLN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.84B | $28.43B | 45.4% | 26.4% | — | $1.30B |
| FY 2024 | $20.18B | $25.51B | 45.2% | 27.3% | — | $1.42B |
| FY 2023 | $19.37B | $23.23B | — | — | — | $639.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDX // BETA 1.06
MDLN // BETA 1.11